Health care professionals' views on hospital pharmacist prescribing in the United Kingdom

International Journal of Pharmacy Practice

Volumn 6, Issue 3, 1998, Pages 159-169

  Child, Damian ^a,b,d   Hirsch, Christine ^a   Berry, Michael ^c  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE; HEALTH CARE QUALITY; HOSPITAL CARE; HOSPITAL PHYSICIAN; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL EDUCATION; NURSE; PATIENT CARE; PHARMACIST; POSTGRADUATE EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

EID: 0031731326     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1998.tb00932.x     Document Type: Article

References (71)

1. Hatoum HT, Catizone C, Hutchinson RA, Purohit A. An 11-year review of the pharmacy literature: Documentation of the value and acceptance of the pharmacist. Drug Intell Clin Pharm 1986;20:33-42.
2. Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: Inpatient care and cost reduction. Drug Intell Clin Pharm Ibid 1988;22:252-9.
3. Hawkey CJ, Hodgson S, Daneshmend TK, Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ 1990;300:986-90.
4. Haig GM, Kiser LA. Effect of pharmacist participation on a medical team on costs, charges and length of stay. Am J Hosp Pharm 1991;48:1457-62.
5. Lobas NH, Lepinski PW, Abramowitz PW. Effect of pharmaceutical care on medication cost and quality of patient care in an ambulatory care clinic. Am J Hosp Pharm Ibid 1992;49(7):1681-8.
6. Bjornson DC, Hiner WO, Potyk RP, Nelson BS, Lombard FA, Morton TA, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm Ibid 1993;50(9):1875-84.
7. Maguinness JA, Macfayden E, Coote JC. Routine discharge prescription monitoring by clinical pharmacists. Pharm J 1992;248:294-5.
8. Dobrzanski S, Reidy F. The pharmacist as a discharge medication planner in surgical patients. Pharm J Ibid 1993;250:HS53-6.
9. Elfellah MS, Jappy BM. Outcomes following discharge prescription monitoring by the ward pharmacist. Pharm J Ibid 1996;257:156-7.
10. Hanlon JT, Weinberger M, Samsa GP et al. A randomized controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.
11. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health-Syst Pharm 1997;54:554-8.
12. Dong BJ. Pharmacist involvement in a thyroid clinic. Am J Hosp Pharm 1990;47:356-61
13. Stimmell GL, McGhan WF, Wincor MZ, Deandrea DM. Comparison of pharmacist and physician prescribing for psychiatric inpatients. Am J Hosp Pharm Ibid 1982;39:1483-6.
14. Furmaga EM. Pharmacist management of a hyperlipidaemia clinic. Am J Hosp Pharm Ibid 1993;50:91-5.
15. McGhan WF, Stimmel GL, Hall TG, Gilman TM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care 1983;21(4):435-44.
16. Morreale AP. Pharmacist managed Helicobacter pylori clinic. Am J Health-Syst Pharm 1995;52;183-5.
17. Macregor SH, Hamley JG, Dunbar JA, Dodd TRP, Cromarty JA. Evaluation of a primary care anticoagulant clinic managed by a pharmacist. BMJ 1996;312:560.
18. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-80.
19. Parekh R, Ghee C. Evaluation of a pharmacist controlled anticoagulant clinic. Br J Pharm Pract 1987;10:370-81.
20. Radley AS, Hall J. The establishment and evaluation of a pharmacist-developed anticoagulant clinic. Pharm J 1994;252:91-2.
21. Farrell J, North-Lewis P, Cross M. Pharmacist prescribing in the United States. Pharm J Ibid 1997;259:187-90.
22. Shefcheck SL, Thomas J. The outlook for pharmacist initiation and modification of drug therapy. J Am Pharm Assoc 1996;NS36(12):597-604.
23. Galt KA. The key to pharmacist prescribing: Collaboration. Am J Health-Syst Pharm 1995;52:1696-9.
24. Stimmell GL, McGhan WF. The pharmacist as prescriber of drug therapy: The USC pilot project. Drug Intell Clin Pharm 1981;15:665-72.
25. Appelbe GE, Wingfield J. Dale and Appelbe's Pharmacy Law and Ethics. 6th ed. London: The Pharmaceutical Press, 1997.
26. Brown T. Development of a protocol for nurse prescribing. Hosp Pharm 1997;4:26-8.
27. Hamley JG. Pharmacists as prescribers. Hosp Pharm Ibid 1997;4(1):2.
28. Medicines, ethics and practice. A guide for pharmacists. Number 19. London: The Royal Pharmaceutical Society of Great Britain, 1998:5-6.
29. Cross MA. Hospital pharmacist prescribing in the new age. Pharm J 1996;257:286-8.
30. Franke DE. The pharmacist prescriber. Drug Intell Clin Pharm 1986;20:981-2.
31. Doering PL. Pharmacists as prescribers: The Florida experience. Drug Intell Clin Pharm 1986;20:983-4.
32. Whittenburg SJ. Obtaining prescribing authority for pharmacists: Lessons learned. Am J Health-Syst Pharm 1995;52:1616-24.
33. Ryan M, Bond C. Dispensing physicians and prescribing pharmacists. Pharmacoeconomics 1994;5(1):8-17.
34. Pharmacist prescribing. National Pharmaceutical Association Supplement 1997; September, Number 819.
35. Society calls for broad prescribing role for pharmacists. Pharm J 1997;259:399-403.
36. Identification of the pharmacist's role [editorial]. Pharm J Ibid 1976;216:271-2.
37. Webb CE. Prescribing medications: Changing the paradigm for a changing health care system. Am J Health-Syst Pharm 1995;52:1693-5.
38. Carmichael JM. Do pharmacists need prescribing privileges to implement pharmaceutical care? Am J Health-Syst Pharm Ibid 1995;52:1699-1701.
39. Penna RP. Pharmacy: A profession in transition or a transitory profession? Am J Hosp Pharm 1987;44:2053-9.
40. Sims J. Who will be able to prescribe ? Pharm Pract 1997;7(9):497-502.
41. A report on the supply and administration of medicines under group protocols. Health Services Circular HSC 1998/051. Leeds: NHS Executive, April 21, 1998.
42. Crown report delayed until June. Pharm J 1998;260:77.
43. Designing and administering questionnaires. Pharmacy Practice Research Resource Centre Bulletin 1992;1(1):1-3.
44. Sexton J, Brown A. Epi-info: A tool for audit and research. Pharm J 1994;253:100-2.
45. Hebron B, Jay C. Pharmaceutical care for patients undergoing elective ENT surgery. Pharm J Ibid J 1998;260:65-6.
46. Stimmel GL. Political and legal aspects of pharmacist prescribing. Am J Hosp Pharm 1983;40(8):1343-4.
47. Dodds LJ. An objective assessment of the role of the pharmacist in medication and compliance history taking. Br J Pharm Pract 1982;4:12-24.
48. Gurwich EL. Comparison of medication histories acquired by pharmacists and physicians. Am J Hosp Pharm 1983;40:1541-2.
49. Jay C. The role of the pre-admissions pharmacist. Hosp Pharm 1998;5:105-6.
50. Cantrill JA, Clark CM. Discharge counselling by pharmacists: The need and the reality. Hosp Pharm Pract 1992;2(6):429-33.
51. Thomas RE. Discharge prescription monitoring. A role for the pharmacist? Hosp Pharm Pract Ibid 1991;1(7):333-7.
52. Culshaw M, Dawes S. Assessing the value of a "discharge pharmacist." Pharm Manage 1998;14(2):22-3.
53. Covington TR. Towards a rational approach to the issue of prescribing authority for pharmacists. Drug Intell Clin Pharm 1983;17(9):660-6.
54. Desikan R, Holiday-Goodman M, Siganga R W, Lively B T. Prescribing authority: An examination of Ohio pharmacists' opinions. Am Pharm 1995;NS35:19-23.
55. Cooke, J, Standing VF. Nurse prescribing. Advantages, disadvantages and future implications. Pharmacoeconomics 1995;8(4):271-4.
56. Livingstone C. Doctors diagnose, but who prescribes? Pharm J 1997;258:767.
57. McCombs JS, Nichol MB, Johnson KA, Hay JW, Ebin VJ, Lawrence GD, Schneider JS. Is pharmacy's vision of the future too narrow? Am J Health-Syst Pharm 1995;52:1208-14.
58. Pharmacy. The report of a committee of inquiry appointed by the Nuffield Foundation. London: Nuffield Foundation, 1986.
59. Cowen DL. Changing relationships between pharmacists and physicians. Am J Hosp Pharm 1992;49:2715-20.
60. Webb CE. Prescribing medications: Changing the paradigm for a changing health care system. Am J Health-Syst Pharm 1995;52:1693-95.
61. Manpower planning, pay and pre-registration training. Pharm J 1996;256:835-6.
62. Four years and a recruitment crisis. Pharm J Ibid 1996; 256: 836.
63. Guild accepts 2.8 per cent pay increase, but predicts manpower crisis. Pharm J Ibid 1997;259:201.
64. Major hospital pharmacy problems foreseen during 2001 and 2002. Hosp Pharm 1998;5(2):32.
65. Howe J. NHS Executive pharmacy workforce and training working group report. Department of Health Publications, March 1997
66. Knapp KK. Pharmacy manpower: Implications for pharmaceutical care and health care reform. Am J Hosp Pharm 1994;51:1212-20.
67. Beecham L. UK needs an extra 1000 doctors. BMJ 1997;315:1487.
68. Shane RR. Pharmacy without walls. Am J Health-Syst Pharm 1996;53:418-25.
69. Rogers A. How to extend technicians' roles. Pharm Pract 1997;7(11):589-92.
70. Key opportunities in pharmacist prescribing. Pharm J 1997;258:765.
71. NPA wants pharmacist prescribers . . . and so does the PSNC. Pharm J Ibid 1997;259:392.